EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Recent Advances in the Management of Heart Failure, Including the Role of AI and Advances in Gene Therapy

Lakshmi Kattamuri iD, Kunal Sharma, Debabrata Mukherjee iD

International Journal of Angiology · 2026-12 · 35 (04) · 322-335

DOI: 10.1055/a-2904-8847 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Angiology, online erschienen am 13.07.2026. Verfasst von Lakshmi Kattamuri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal MedicineTexas Tech University Health Sciences Center El PasoEl PasoTexasUnited States. Die Arbeit nennt 154 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) remains a major cause of morbidity and mortality despite significant advances in its management. This study aimed to synthesize recent advances in HF management, including the role of artificial intelligence (AI) and advances in gene therapy. PubMed, Embase, Web of Science, and Google Scholar were searched for original research (2020–January 2026) on recent advances in HF management, including AI and gene-based therapies. While guideline-directed management and therapy (GDMT) substantially reduce mortality and hospitalization in heart failure with reduced ejection fraction (HFrEF), utilization of such therapies is frequently constrained by delayed initiation, incomplete titration, noncompliance, and cost. Beyond foundational therapy, finerenone, sodium glucose cotransporter-2 inhibitors (SGLT2i) across the ejection fraction (EF) spectrum, and glucagon-like peptide-1 receptor agonist (GLP-1 RA) for obesity-related heart failure with preserved ejection fraction (HFpEF) extend phenotype-directed options. Transcatheter mitral and tricuspid repair/replacement has shifted mitral and tricuspid regurgitation from a bystander lesion to a treatable contributor to improvement of symptoms and quality of life. Adjunctive transcatheter mitral interventions have expanded treatment options for selected symptomatic HFrEF patients with secondary mitral regurgitation (MR) despite optimized GDMT, improving MR severity, functional status, and reducing HF hospitalizations. Donor-derived cell-free DNA rejection surveillance, donation after circulatory death to expand donor supply, and refinement of left ventricular assist device (LVAD) antithrombotic strategies are evolving in advanced HF. AI tools and gene therapies are showing promising results but require further large-scale studies for validation and clinical adoption. Contemporary HF management is increasingly phenotype- and trajectory-guided, but its clinical adoption is limited by optimal implementation and access barriers. Future research should focus on outcomes-based validation with a clear patient-selection framework to enable durable real-world implementation to improve outcomes further.

Schlagwörter

Stichwörter der Autor:innen

SGLT2 inhibitorsartificial intelligencegene therapyguideline-directed management and therapyheart failuremitral regurgitationtricuspid regurgitation

Autor:innen und Institutionen

  • Department of Internal MedicineTexas Tech University Health Sciences Center El PasoEl PasoTexasUnited States.
  • Division of CardiologyDepartment of Internal MedicineTexas Tech University Health Sciences Center El PasoEl PasoTexasUnited States.

ORCID-Profile: Lakshmi Kattamuri, Debabrata Mukherjee

Zitieren

APA

Kattamuri, L., Sharma, K., & Mukherjee, D. (2026). Recent Advances in the Management of Heart Failure, Including the Role of AI and Advances in Gene Therapy. International Journal of Angiology, 35(04), 322-335. https://doi.org/10.1055/a-2904-8847

Vancouver

Kattamuri L, Sharma K, Mukherjee D. Recent Advances in the Management of Heart Failure, Including the Role of AI and Advances in Gene Therapy. International Journal of Angiology. 2026;35(04):322-335. doi:10.1055/a-2904-8847

BibTeX
@article{Kattamuri2026,
  author = {Kattamuri, Lakshmi and Sharma, Kunal and Mukherjee, Debabrata},
  title = {Recent Advances in the Management of Heart Failure, Including the Role of AI and Advances in Gene Therapy},
  journal = {International Journal of Angiology},
  year = {2026},
  volume = {35},
  number = {04},
  pages = {322--335},
  doi = {10.1055/a-2904-8847}
}
Kostenlos starten →